This product, Glutathione, is an unlicensed medicine in the United Kingdom.
It has not been assessed by the MHRA for quality, safety, or efficacy.

It is licensed in Italy for the prophylaxis of neuropathies following chemotherapy with cisplatin or cisplatin analogues.

Any other uses of this medicine are unlicensed and may carry undetermined risks, for which the prescriber is responsible.

The prescriber and patient must be informed of the unlicensed status of this medicine before use.

This information is provided for healthcare professionals and organisations only.

Please contact enquiries@gadpharma.com for more information